← FDA DRUG APPROVALS

FDA ANDA · ANDA065206

CLINDAMYCIN PHOSPHATE

Sponsor: HIKMA

APPLICATION
ANDA065206
TYPE
ANDA
ORIGINAL APPROVAL
2004-09-24
LATEST ACTION
2011-12-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CLINDAMYCIN PHOSPHATEPrescription
CLINDAMYCIN PHOSPHATE EQ 150MG BASE/ML · INJECTABLE · INJECTION

Approval history

2011-12-20Labeling · Supplement 7AP
2008-07-30Labeling · Supplement 4AP
2007-06-19Labeling · Supplement 2AP
2004-09-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →